Alerts

4668 total results. Page 168 of 187.

Anthony V. Lupo

The Federal Trade Commission announced this week that it settled with two marketers of mobile medical apps — New Consumer Solutions LLC and Health Discovery Corp. — for claiming that their MMAs (Mole Detective and MelApp, respectively) could diagnose melanoma from photographs of the users’ moles.

Peter V. B. Unger, M. Scott Peeler, Terree A. Bowers

Alstom SA’s release today from World Bank sanctions ensures that the US Department of Justice (DOJ) will not impose an independent corporate monitor under its recent settlement with the company.

Brian P. Waldman

March 1 is fast approaching. It is the deadline for consumer and commercial product companies to complete an electronic submission to the California Air Resources Board’s (CARB) “2013 Consumer and Commercial Products Survey” (Survey).

Lee M. Caplan

The US National Contact Point recently issued a Final Statement regarding complaints by two international labor unions that Nissan Motor Co., Ltd. and Nissan North America, Inc. (Nissan) engaged in conduct inconsistent with the OECD Guidelines for Multinational Enterprises (OECD Guidelines).

Stanley H. Abramson, Wayne H. Matelski, Brian P. Waldman

On January 28, 2015, Sen. Richard Durbin (D-IL) and Rep. Rosa DeLauro (D-CT) introduced respective companion food safety legislation in the Senate (S.287, the “Safe Food Act of 2015”) and House (HR.609).

Jon S. Bouker, Richard A. Newman, Richard L. Brand, Thorne Maginnis

President Barack Obama recently released his budget proposal for Fiscal Year 2016, and municipalities, sports franchises, and owners of sports and entertainment facilities across the country will pay special attention to one line in particular.

The long-awaited final Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) provisions modifying the Human Trafficking regulations were published on January 29, 2015.

David R. Hamill, Birgit Matthiesen

In September 2014, Arent Fox reported about a US court case with which every corporate officer of a company doing business in the United States should become familiar.

Wayne H. Matelski

The US Food and Drug Administration (FDA) recently issued a draft guidance entitled “Transfer of a Premarket Notification (510(k)) Clearance — Questions and Answers — Draft Guidance for Industry and Food and Drug Administration Staff.”

Brian P. Waldman

The US Food and Drug Administration (FDA) recently issued a draft guidance document announcing that it does not intend to regulate low-risk products intended for general wellness only as medical devices.

Lee M. Caplan

Many companies and other stakeholders have chosen to participate in the United Nations (UN) Global Compact as a means of demonstrating their commitment to integrating universal Corporate Social Responsibility (CSR) principles into their business practices.

Arent Fox filed an amicus brief for the Law Center to Prevent Gun Violence in the 9th Circuit matter Teixeira v. County of Alameda.

M. Scott Peeler, Peter V. B. Unger

Foreign Corrupt Practices Act (FCPA) violations can lead to significant collateral consequences.

The last decade has seen enormous growth in the human tissue products industry, following the Food and Drug Administration’s establishment, in 2001, of a tiered approach to the regulation of these products (referred to as “human cells, tissues and cell- and tissue-based products,” or “HCT/Ps”).

Anthony V. Lupo, Debra Albin-Riley

On January 12, 2015, California’s Office of Environmental Health Hazard Assessment (OEHHA) issued a proposed regulation to revise the required warning statement for products containing chemicals listed by the state under Proposition-65 (Prop-65).

Kay C. Georgi

In 2014, the Departments of State and Commerce implemented final rules that overhauled 11 United States Munitions List (USML) Categories. These changes have affected a wide range of industries.

Hunter T. Carter

Most parties that enter into arbitration agreements do not expect their choice to be diminished by being forced to litigate in open court. This paramount deference to contractual freedom is a hallmark of US law as well as the practice in the United States Court of Appeals for the Second Circuit.

Birgit Matthiesen, David R. Hamill

Your company has been asked by a customer to certify that its products manufactured in US plants are in compliance with “Buy American” requirements. How does your company respond?

David R. Hamill, Birgit Matthiesen

Your company has been asked by a customer to certify that its products manufactured in US plants are in compliance with “Buy American” requirements. How does your company respond?

Anthony V. Lupo, Matthew R. Mills, Amy (Salomon) McFarland, Dan Jasnow

In a succinct eight-page opinion, the Supreme Court ruled unanimously last week that trademark “tacking” is a question of fact that should generally be decided by juries.

Brian P. Waldman, Wayne H. Matelski

The Food and Drug Administration (FDA) has just issued its long-awaited Draft Guidance on Current Good Manufacturing Practice (CGMP) Requirements for Combination Products.

Dan H. Renberg, Jon S. Bouker

On January 16, 2015, Sens. Jerry Moran (R-KS) and Mark Warner (D-VA) introduced S. 181 (The Startup Act), which is meant to promote new business formation, especially in the information technology industry.

Matthew Nolan, Kay C. Georgi

The Treasury Department’s Office of Foreign Assets Control and the Commerce Department’s Bureau of Industry and Security released their much-anticipated regulations governing trade with Cuba, and they were published in the Federal Register and became effective on January 16, 2015.

Alan G. Fishel, Adam D. Bowser

On January 15, 2015, the Federal Communications Commission’s (FCC) Notice of Proposed Rulemaking (NPRM) regarding the scope of its definition of “multichannel video programming distributors” (MVPDs) was published in the Federal Register.

Henry Morris, Jr.

Should you choose federal litigation or arbitration? In arbitration, parties to a dispute agree to submit the dispute for a decision to a neutral third party who is not a public official. Advantages include limited discovery while disadvantages include narrower grounds for appeal.